Percutaneous insertion of a novel dedicated metal stent to treat malignant hilar biliary obstruction

Table 3 Patients with stent-related complications

Age/sex	Etiology	Clinical manifestations	US findings	PTC findings	Treatment
75/F	GC	Jaundice	Left intrahepatic biliary dilatation	Stent migration	Additional MCS using SIS technique
77/M	CC	Jaundice	Bilateral intrahepatic biliary dilatation	Stent occlusion	PTBD
68/F	CC	Cholangitis	Aerobilia and no biliary dilatation	Not performed	Antibiotic therapy
81/M	CC	Cholangitis	Aerobilia and no biliary dilatation	Not performed	Antibiotic therapy
75/F	CC	Cholangitis	Aerobilia and no biliary dilatation	Not performed	Antibiotic therapy

GC: Gallbladder carcinoma; CC: Cholangiocarcinoma; US: Ultrasound; PTC: Percutaneous transhepatic cholangiography; MCS: Moving Cell Stent; PTBD: Percutaneous transhepatic biliary drainage; SIS: Stent-in-stent.